Temporarily blocks the release of neurotransmitters in the muscles, inhibiting muscle contraction and reducing muscle volume.

Manufactured using a vacuum-drying process. Pre-clinical studies (MRI and EMG on rat models) demonstrate high muscle relaxation activity and volume reduction efficacy comparable to leading global brands.

Temporary improvement of moderate to severe wrinkles and reduction of targeted muscle volume.

Glabellar wrinkles associated with the activity of the corrugator and/or procerus muscles in adults between the ages of 19 and 65.

Pre-clinical studies indicate significant muscle reduction from 4 weeks post-injection, sustained up to 24 weeks.

Use immediately or within 24 hours after reconstitution.

Localized pain, swelling, redness, bruising, or mild headaches.

• Avoid rubbing or massaging the treated area.
• Refrain from strenuous exercise or saunas for a few days post-treatment.

FINETOX 100 Units is used for temporary improvement of moderate to severe wrinkles and reduction of targeted muscle volume, specifically glabellar wrinkles associated with the activity of the corrugator and/or procerus muscles in adults between the ages of 19 and 65.

Pre-clinical studies indicate significant muscle reduction from 4 weeks post-injection, sustained up to 24 weeks.

It is administered by intramuscular injection. Dissolve in sterile normal saline to form a transparent solution prior to administration.

FINETOX 100 Units is for professional medical use only and should be administered by a qualified medical professional.

FINETOX 100 Units is manufactured by Daejong Meditec Co., Ltd.